Tumor Tissue Equipment
-
Manufactured by Veracytebased in FRANCE
Veracyte offers a unique multiplex tissue imaging and analysis approach combining multiple technologies perfectly adapted to the comprehensive characterization of the tumor microenvironment. ...
-
based in USA
Our DecisionDx-CMSeq is a 3-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to cutaneous melanoma in melanoma tumor tissue. The test includes hotspot mutations in the genes BRAF, NRAS and ...
-
Manufactured by Atlantherabased in FRANCE
Specific targeting of tumor bone tissue, Potent antitumor activity, Low systemic toxicity, Prevention of bone ...
-
Manufactured by TxinnoBioscience Inc.based in SOUTH KOREA
Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. The first one is defined as tumor-intrinsic factors which are either genes or signaling pathways of tumor cells to directly control tumor cell proliferation or survival. Corresponding assets ...
-
Manufactured by Onkos Surgicalbased in USA
Every tumor, fracture, and complex revision case is different. Using My3DTM technology, ONKOS SURGICAL develops personalized implant, instrument and anatomic model designs to aid surgeons when performing operative procedures. Highly qualified image processors segment CT scans to create 3D computer models of the hard and soft (tumor) ...
-
Manufactured by Celyad Oncologybased in BELGIUM
-inflammatory cells within tumor tissue. CYAD-203 is currently being evaluated in Investigational New Drug (IND)-enabling studies and submission of the IND application for treatment of solid tumors is expected in ...
-
Manufactured by CytomX Therapeutics, Inc.based in USA
Probody therapeutics are designed to outsmart cancer by exploiting the unique conditions of the tumor microenvironment to more effectively localize treatment to the tumor, while limiting activity in healthy tissues. These novel therapies are designed to take advantage of high levels of protease activity in the tumor ...
-
Manufactured by OncoDNA S.A.based in BELGIUM
of tumor tissue, our biomarker test is able to pinpoint the therapeutic vulnerabilities of a tumor and identify appropriate cancer treatment options in a fast ...
-
based in USA
NeoTherma Oncology is a clinical stage medical device company developing a proprietary Thermal Treatment (VectRx) system for deep solid tumors. Our technology is based on applying a safe, non-invasive, non-ionizing electromagnetic field to produce local-regional hyperthermic temperatures in tumor tissue, intended to increase the ...
-
based in USA
Our DecisionDx-UMSeq is a 7-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to uveal melanoma. Researchers believe that identifying mutations in tumor genes may someday help guide treatment decisions. Because the amount of tumor biopsy tissue is limited, it is important to gain as much ...
-
based in USA
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ prepared from a patient’s tumor tissue that Metaclipse modifies with a ‘protein ...
-
Manufactured by Datar Cancer Geneticsbased in UNITED KINGDOM
these CTCs from the blood sample and confirms their identity via a process called ‘Immunocytochemistry’ (ICC). Pinaka also determines the status of the above biomarkers on CTCs either via ICC or by fluorescent in situ hybridization (FISH). Patients diagnosed with some types of cancers may be advised additional testing of tumor tissue ...
-
Manufactured by SynVivo, Inc.based in USA
SynTumor is a 3D tissue model for real-time visualization and quantitative assessment of cell-cell and cell-drug interactions in a physiologically and morphologically realistic tumor microenvironment. The system enables (a) circulation in the microvasculature, (b) transport across the vessel walls, and (c) delivery to the tumors. ...
-
Manufactured by provitro AGbased in GERMANY
Neoplastic (tumour) TMA include various neoplasms which are precisely graded, typed and classified according to WHO and/or UICC ...
-
Manufactured by Transgenebased in FRANCE
A particularly innovative immunotherapy, TG4050 is the lead myvac® candidate. This individualized treatment is based on the specific mutations that are identified in each patient’s ...
-
Manufactured by SOMATEX Medical Technologies GmbHbased in GERMANY
Tuloc is used for marking non-palpable, suspicious breast lesions prior to surgery. The monofilament, rigid marking wire facilitates the intraoperative localization of findings for surgeons. Sharp, 20-Gauge puncture cannulas ensure patient-friendly ...
-
Manufactured by Olfactomicsbased in FINLAND
Olfactomics Resect analyzes plume generated by an energy device as the surgeon operates, enabling comprehensive margin assessment without additional ...
-
Manufactured by Zionexabased in USA
Z-FLD is an in-vivo biomarker drug candidate with a high specificity and high positive predictive value, demonstrated for indolent ...
-
based in ISRAEL
Combines image-guided planning and real-time monitoring with precise robotic insertion and S-Drive™ technology to deliver instruments to the desired target in the body with enhanced accuracy, consistency, and efficiency. ...
-
Manufactured by Datar Cancer Geneticsbased in UNITED KINGDOM
CellDx is an intensive and in-depth tumor molecular profiling. It analyses millions of data points at the molecular level to reveal threats and vulnerabilities which enable optimal identification of targets for precision treatment ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you